OR WAIT null SECS
Kevin Gopal is Pharmaceutical Executive's international correspondent, covering pharma and regulatory issues around the word. He is also a political columnist for North West Business Insider, one of the UK's leading regional business magazines. He started his career as a journalist at SiYu, the UK's Chinese community magazine, before joining the PE staff.
Huntingdon, UK-Huntingdon Life Sciences, a contract research organization under siege by animal rights activists, secured its short-term future through a refinancing package offered by overseas institutions.